TREATMENTS FOR HEART FAILURE AND CARDIAC ISCHAEMIC REPERFUSION INJURY

The present invention relates to the use of extracorporeal cardiac shockwave therapy in the treatment or prophylaxis of heart disease, in particular the invention provides a dipeptidyl peptidase-4 (DPP-4) inhibitor, or a pharmaceutical composition containing said inhibitor, for use in: (a) treating...

Full description

Saved in:
Bibliographic Details
Main Author NARODDEN, Salomon
Format Patent
LanguageEnglish
Published 26.01.2024
Subjects
DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SURGERY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of extracorporeal cardiac shockwave therapy in the treatment or prophylaxis of heart disease, in particular the invention provides a dipeptidyl peptidase-4 (DPP-4) inhibitor, or a pharmaceutical composition containing said inhibitor, for use in: (a) treating or preventing heart failure; or (b) treating cardiac ischaemic reperfusion injury, in a subject, wherein said subject has been administered extracorporeal cardiac shockwave therapy and wherein said inhibitor is for administration prior to, simultaneously with, and/or after administration of said shockwave therapy. (The most illustrative drawing: Figure 10)
Bibliography:Application Number: MY2019PI02914